Rep. Pete Sessions

Maddy summaryThe Foreign Propaganda Disclosure Act amends the Foreign Agents Registration Act to explicitly include social media influencers in its regulatory scope. The bill defines a social media influencer as any individual who maintains a monetized account on a social media platform, using an existing definition from the Trafficking Victims Prevention and Protection Reauthorization Act of 2022. By making this addition, the legislation requires these specific digital content creators to comply with the same registration and disclosure obligations currently applied to other foreign agents.

Maddy summaryHR 2555, the Freedom of Association in Higher Education Act of 2025, protects students who join or form single-sex social organizations (like fraternities or sororities) at colleges. It prohibits colleges receiving federal funds from taking negative actions against these students or organizations solely because they limit membership to one sex - such as denying housing, financial aid, leadership roles, or recognition. The bill ensures students can join such groups without coercion and stops colleges from imposing unfair recruitment rules on single-sex organizations compared to others. It does not require colleges to recognize single-sex groups, allow organizations to set their own membership rules, or override Title IX protections.

Maddy summaryThis House resolution formally honors the life and legacy of the late Representative Kay Granger from Texas, recognizing her historic achievements in public service. The bill highlights her roles as the first woman elected mayor of Fort Worth, the first Republican woman to represent Texas in the U.S. House, and the first Republican woman to chair the House Committee on Appropriations. It also acknowledges her contributions to national defense, including her work on the F-35 fighter jet program and the naming of a Navy ship for Fort Worth. The resolution expresses sympathy to Granger's family and directs the Clerk of the House to send an official copy of the document to her loved ones.

Maddy summaryThe American Patients First Act of 2026 establishes a new payment rate of $457 per square centimeter for skin substitute products used in Medicare between 2027 and 2030, provided these products are manufactured entirely within the United States using domestically sourced materials. To ensure compliance, the bill defines these products as those made from U.S. human tissue or synthetic materials and requires that all harvesting, processing, and manufacturing occur exclusively in the country, though the Secretary of Health and Human Services may grant temporary waivers for up to 180 days if domestic supply shortages threaten patient access. The legislation also introduces stricter oversight measures, including prepayment claim reviews, prior authorization requirements for certain providers, and limits on payment if a product was purchased for less than a specific threshold price. Additionally, the act mandates that only providers certified by specific wound care organizations can bill for these products and restricts reimbursement for wastage or repeated applications without clinical improvement. Finally, the bill requires the HHS to submit a report to Congress by 2030 analyzing the cost of producing these products and evidence of their effectiveness.

Maddy summaryThis resolution expresses the sense of the House of Representatives that Charleston, South Carolina, should proceed with hosting the 2027 annual meeting of the Organization for Security and Cooperation in Europe Parliamentary Assembly. The bill cites Charleston's existing facilities as suitable for the event and notes that hosting the convention in South Carolina honors the legacy of late Senator Lindsey Olin Graham. It also highlights that the United States has not hosted this specific assembly since 2005. The measure does not change any laws or allocate funding but serves as a formal statement of support for the planned event.

Maddy summaryThe Stop EU Overreach Act directs the United States Trade Representative to initiate a formal investigation within 30 days of enactment to determine if specific European Union environmental and sustainability regulations unfairly burden American commerce. These targeted measures include rules on corporate sustainability due diligence, reporting, deforestation traceability, and carbon border adjustments that apply to US companies based on their operations or supply chains outside the EU. If the investigation concludes that these foreign practices are unreasonable or discriminatory, the USTR is authorized to take retaliatory actions such as imposing duties on imports from EU member states or suspending trade agreement benefits. The bill includes a sunset provision that terminates its requirements for any specific EU measure once the USTR certifies that the European Union has repealed the rule or entered into a binding agreement to exempt US persons from its extraterritorial obligations.

Maddy summaryThis bill reauthorizes and expands the Accelerating Access to Critical Therapies for ALS Act through 2031, extending funding for research into treatments for amyotrophic lateral sclerosis. It requires drug manufacturers to share interim clinical trial data with the FDA to better assess the progress of investigational drugs and clarifies that phase 3 clinical trial definitions include combined phase 2/3 trials and planned trials not yet enrolling participants. The legislation also mandates the FDA to publish an updated five-year action plan for ALS and other rare neurodegenerative diseases, including resource needs and coordination strategies with broader disease communities. Additionally, the bill requires the Government Accountability Office to submit a report on the program's implementation four years after enactment.

Maddy summaryThis bill, known as the D.C. Taxing Authority Review Act, modifies the rules for how new taxes and fees proposed by the District of Columbia government are reviewed by Congress. It requires that any D.C. law imposing or increasing a tax or fee must receive explicit approval from a joint resolution passed by both the House of Representatives and the Senate within 60 days, or else the law will not take effect. Additionally, the bill limits the time for debating these specific approval resolutions to one hour, split evenly between supporters and opponents. These changes directly affect the District of Columbia government's ability to enact new financial measures without prior congressional consent.

Maddy summaryThe Main Street Capital Access Act reduces regulatory burdens for smaller banks, particularly those with less than $10 billion in assets. Key provisions include a 3-year phase-in period for new banks to meet capital requirements, lower leverage ratio requirements for rural banks (7.5% for the first 2 years), and a 30-day review process for business plan deviations. The bill also establishes an Office of Independent Examination Review, sets specific timelines for examinations (270 days) and reports (90 days), and creates a "least cost exception" for bank resolutions to prevent excessive concentration of the banking system. These changes aim to promote new bank formation, improve regulatory efficiency, and support community banking while maintaining financial stability.

Maddy summaryThis bill requires pharmacy benefits managers (PBMs) administering prescription drug benefits for federal employee health plans to reimburse pharmacies at specific rates, including the national average drug cost plus a small percentage or $50, whichever is lower. It prohibits PBMs from favoring their own pharmacies, restricting patient choice, or reducing pharmacy payments after claims are processed. The bill establishes $10,000 civil penalties for violations, with debarment from federal health plans after 10 penalties in 10 years. This directly affects PBMs, in-network pharmacies, and federal health benefit plans covering millions of federal employees and their families. The law aims to ensure fair reimbursement practices and maintain pharmacy choice under the Federal Employees Health Benefits Program.